Unverified50% confidenceFactExact time
The second paper presents experimental validation of de novo antibody design, completing the full closed loop of design, synthesis, and testing.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/21/2026
First Seen
Valid until: 12/20/2026
Sources
Related Entities
Related Claims
UnverifiedThe first paper focuses on establishing a unified evaluation benchmark for antibody binding affinity prediction models.69% similarUnverifiedUnder healthcare safety requirements, the industry generally recommends a dual-verification mechanism of AI pre-screening plus manual confirmation for prescription parsing.61% similarUnverified测试自愈概念并非 Text2Test 首创，Testim（被 Tricentis 收购）、Healenium、Mabl 等工具早在2018-2020年间就提出了类似能力60% similarUnverified诊断故障时形成'诊断—操作—验证'的完整闭环，通过二次验证可提升诊断可信度60% similarUnverifiedThe paper's validation was completed on constructed diagnostic environments and synthetic data, while validation on real physical robots and VLA (Vision-Language-Action) models remains to be done.59% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/939203API
curl https://kongchang.com/api/v1/knowledge/claims/939203MCP
get_claim(id=939203)